Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts

P D Stein1, J E Dalen, S Goldman

  • 1Henry Ford Health System, Cardiac Wellness Center, Detroit, MI 48202-3006, USA. pstein1@hfhs.org

Chest
|November 20, 1998
PubMed

Insights

Aspirin effectively reduces saphenous vein bypass graft occlusion for one year when initiated perioperatively. However, extended aspirin use beyond one year offers no additional graft patency benefits.

Area of Science:

  • Cardiovascular Surgery
  • Pharmacology
  • Thrombosis Research

Background:

  • Saphenous vein graft (SVG) occlusion is a significant complication after coronary artery bypass grafting (CABG).
  • Preventing SVG occlusion is crucial for long-term graft patency and patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of aspirin and other antithrombotic agents in preventing saphenous vein bypass graft occlusion.
  • To assess the impact of timing and duration of aspirin therapy on graft patency and bleeding complications.

Main Methods:

  • Systematic review and analysis of clinical trials investigating antithrombotic agents for SVG patency.
  • Comparison of aspirin (various doses and timings), aspirin plus dipyridamole, ticlopidine, and oral anticoagulants against placebo or control groups.

Main Results:

  • Aspirin (325-900 mg/d) initiated preoperatively or on the day of surgery effectively reduced SVG occlusion for one year.
  • Aspirin combined with dipyridamole showed no added benefit over aspirin alone.
  • Increased bleeding risk was observed with aspirin initiation one day before surgery.
  • Ticlopidine demonstrated efficacy in maintaining graft patency when started postoperatively.
  • Oral anticoagulants yielded inconsistent results for SVG patency maintenance.
  • Extended aspirin use beyond one year did not provide additional long-term graft patency benefits.

Conclusions:

  • Perioperative aspirin initiation is effective in reducing short-term saphenous vein bypass graft occlusion.
  • Long-term aspirin therapy beyond one year does not enhance graft patency.
  • Bleeding risk should be considered when timing aspirin initiation.
  • Ticlopidine may be an alternative for maintaining graft patency, while oral anticoagulants show limited efficacy.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...